Novel drug targeting leukemia cells enters clinical trial
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia ...
Sep 16, 2014
0
0